| Healthpro Heritage Rehab & Fitness, Llc | |
|
1801 Susquehanna Rd, Abington, PA 19001-4622 | |
| (215) 330-6834 | |
| Not Available |
| Full Name | Healthpro Heritage Rehab & Fitness, Llc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 1801 Susquehanna Rd, Abington, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235653403 | NPI | - | NPPES |
| Provider Name | Lisa C Coppola |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1427100999 PECOS PAC ID: 8426012089 Enrollment ID: I20041115000510 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Daniel Lewis Allen |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1588863062 PECOS PAC ID: 0648361097 Enrollment ID: I20070814000513 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Antoinette F Fabrizio |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1790995678 PECOS PAC ID: 0840327987 Enrollment ID: I20100422000268 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Whitney Steinmetz |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1275657959 PECOS PAC ID: 4880837079 Enrollment ID: I20130909000453 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Pamela B Schick |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1336465327 PECOS PAC ID: 8729210745 Enrollment ID: I20140407000078 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Nathan Varner |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1407277734 PECOS PAC ID: 2466684360 Enrollment ID: I20140408000799 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Jennifer Louise Kistler |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1912241548 PECOS PAC ID: 2769600436 Enrollment ID: I20140822000590 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Marilyn Stanford |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1225229768 PECOS PAC ID: 8325369648 Enrollment ID: I20150611000985 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Scott S Hughes |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1992997670 PECOS PAC ID: 9638466246 Enrollment ID: I20160926001926 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Meredith Jones |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1801341334 PECOS PAC ID: 1052696366 Enrollment ID: I20170329002001 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Jonathan A Cook |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1063934347 PECOS PAC ID: 5294001871 Enrollment ID: I20171026000856 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Justin Owens |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1629435219 PECOS PAC ID: 3072874759 Enrollment ID: I20180220001207 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Alyssa L Saurman |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1538610381 PECOS PAC ID: 8224399506 Enrollment ID: I20180301000764 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Erin C Heller |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1982724761 PECOS PAC ID: 9830452333 Enrollment ID: I20180416001728 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Sara Tye |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1518225184 PECOS PAC ID: 8820332067 Enrollment ID: I20181129000941 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Amanda Catherine Deily |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1528383734 PECOS PAC ID: 2860721750 Enrollment ID: I20190830001950 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Melissa Marie Gibblets |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1568580462 PECOS PAC ID: 6002242971 Enrollment ID: I20200213000040 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Elizabeth Sohns |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1932504289 PECOS PAC ID: 7416384052 Enrollment ID: I20200220002682 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Jennifer Mitchell |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1124505516 PECOS PAC ID: 2961839337 Enrollment ID: I20200224002930 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Lisa Marie Webb |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1427182575 PECOS PAC ID: 0244668192 Enrollment ID: I20200309000406 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Laura Michelle Tylutki-stuble |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1558760900 PECOS PAC ID: 4789012386 Enrollment ID: I20200313001116 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Virginia Cristofoletti |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1154689784 PECOS PAC ID: 3375961899 Enrollment ID: I20200916000526 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Megan Seal |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1427665421 PECOS PAC ID: 2961812003 Enrollment ID: I20201102000407 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Craig Winter |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1184122590 PECOS PAC ID: 4385057686 Enrollment ID: I20210105002813 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Linda Jean Harris |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1760608103 PECOS PAC ID: 0648685313 Enrollment ID: I20210211001237 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Jeannie Hanych |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1912588633 PECOS PAC ID: 2365850815 Enrollment ID: I20210421001776 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Sandra Gochnauer |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1508149956 PECOS PAC ID: 6305245309 Enrollment ID: I20210525000529 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Deanna Marie Spott |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1356639686 PECOS PAC ID: 8729202478 Enrollment ID: I20210628000803 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Emily Coogan |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1073062642 PECOS PAC ID: 9133521800 Enrollment ID: I20210719000241 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Linda M Murphy |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1245832815 PECOS PAC ID: 5092117762 Enrollment ID: I20210719000403 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Marjorie Enriquez Mari |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1528235124 PECOS PAC ID: 0244633931 Enrollment ID: I20210719001396 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Rebecca Lynn Newcomer |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1043880024 PECOS PAC ID: 0648674077 Enrollment ID: I20210809000043 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Deborah Lynn Hoeksema |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1013125806 PECOS PAC ID: 7810392081 Enrollment ID: I20210826000404 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Neeta Tipnis |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1063188985 PECOS PAC ID: 3072918069 Enrollment ID: I20210830002176 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Lauren Marie Rowlands |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1063539807 PECOS PAC ID: 2466858964 Enrollment ID: I20210909000048 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Tiffany Messner |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1801424668 PECOS PAC ID: 1254738321 Enrollment ID: I20210916002850 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Marjorie Meinert |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1700341591 PECOS PAC ID: 4981001773 Enrollment ID: I20210921002669 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Maura Catherine Williams |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1609395185 PECOS PAC ID: 9335547470 Enrollment ID: I20211005000331 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Marco Canlas Udpaga |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1033874870 PECOS PAC ID: 8325437239 Enrollment ID: I20211116000096 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Lindsey Philbin |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1043845381 PECOS PAC ID: 2264822667 Enrollment ID: I20211129000815 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Meredith L O Neal |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1902481963 PECOS PAC ID: 1759771967 Enrollment ID: I20211202000752 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Mackensey Buell |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1588287452 PECOS PAC ID: 6204229867 Enrollment ID: I20220203002342 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Cynthia Altman Montagna |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1962902155 PECOS PAC ID: 9234522319 Enrollment ID: I20220214001385 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Aila Marie Freed |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1750993200 PECOS PAC ID: 2466845425 Enrollment ID: I20220215002173 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Jessica Ball |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1417553017 PECOS PAC ID: 7214321173 Enrollment ID: I20220218001987 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Lauren Marie Matevish |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1598259707 PECOS PAC ID: 5294129284 Enrollment ID: I20220309000721 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Anza Susan Thomas |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1750037503 PECOS PAC ID: 7113312786 Enrollment ID: I20220317000586 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Katherine Elkin |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1871843482 PECOS PAC ID: 2961897384 Enrollment ID: I20220322002677 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Samantha Braun |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1801403779 PECOS PAC ID: 2769878685 Enrollment ID: I20220401000682 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Misty Goyal |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1558867879 PECOS PAC ID: 0840686283 Enrollment ID: I20220411002714 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Sharon A Nemes |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1659400836 PECOS PAC ID: 8325435183 Enrollment ID: I20220425002440 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Katlin Moyer |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1336578236 PECOS PAC ID: 4082091061 Enrollment ID: I20220512001037 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Ariana Isabella Cunningham |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1992444939 PECOS PAC ID: 4486034741 Enrollment ID: I20220704000107 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Jordan Cumbo |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1699404517 PECOS PAC ID: 7416337571 Enrollment ID: I20220707000009 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Pooja Parekh |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1316613771 PECOS PAC ID: 6507234747 Enrollment ID: I20221121000263 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Amanda R Dowling |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1588212781 PECOS PAC ID: 4284002072 Enrollment ID: I20221129002070 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Rachel Lynch |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1699259101 PECOS PAC ID: 2062883812 Enrollment ID: I20230113002641 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Jordan D Bicher |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1598073009 PECOS PAC ID: 8820460421 Enrollment ID: I20230208000693 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Clare Winton |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1740987650 PECOS PAC ID: 9032575642 Enrollment ID: I20230523002385 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Nancy Lee Colbaugh |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1720213945 PECOS PAC ID: 1951769454 Enrollment ID: I20230615000315 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Michele D Wood |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1740471101 PECOS PAC ID: 8022479807 Enrollment ID: I20230726000976 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Michele Hand |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1023599040 PECOS PAC ID: 3375906902 Enrollment ID: I20230830002682 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Heidy Wilderman |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1760675995 PECOS PAC ID: 4082068234 Enrollment ID: I20230921004289 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Allie Winokur |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1487351540 PECOS PAC ID: 7911351093 Enrollment ID: I20230922001871 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Aimee Beth Kretschman |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1770729121 PECOS PAC ID: 4587010228 Enrollment ID: I20231101000170 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Caitlin Burke |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1659086890 PECOS PAC ID: 4082086533 Enrollment ID: I20240116000835 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Jessica Talarico |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1699148700 PECOS PAC ID: 6608228259 Enrollment ID: I20240118003403 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Maureen C. Walsh |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1174778955 PECOS PAC ID: 5496107757 Enrollment ID: I20240123000751 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Harriet Meyer |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1568585297 PECOS PAC ID: 3870946379 Enrollment ID: I20240131004451 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Jenna Evelina Curtiss |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1407617715 PECOS PAC ID: 5597108035 Enrollment ID: I20240212002387 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Lynn M Malik |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1467891325 PECOS PAC ID: 9931543311 Enrollment ID: I20240214001802 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Donya Pt Geagan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1265551139 PECOS PAC ID: 2961846951 Enrollment ID: I20240218000013 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Jessica Monaghan |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1407590607 PECOS PAC ID: 9931543600 Enrollment ID: I20240221001856 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Donna Buzby |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1386021392 PECOS PAC ID: 8527403807 Enrollment ID: I20240226003703 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Provider Name | Ashley Spangler |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1437766763 PECOS PAC ID: 8527404144 Enrollment ID: I20240306000645 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Healthpro Heritage Rehab & Fitness, Llc 536 Old Howell Rd, Greenville, SC 29615-1969 Ph: (864) 244-3626 | Healthpro Heritage Rehab & Fitness, Llc 1801 Susquehanna Rd, Abington, PA 19001-4622 Ph: (215) 330-6834 |
News Archive
Cochlear Limited, the global leader in implantable hearing solutions, announced today the launch of the Communication Corner for their North America region (US and Canada). Communication Corner is a web-based learning program designed to improve communication for people with hearing loss by providing materials and activities specific to each person's needs and level of function.
ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.
› Verified 9 days ago
Julianne Lawler, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1986 Moreland Rd, Abington, PA 19001 Phone: 215-908-0121 | |
Meagan White Merritt, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1801 Susquehanna Rd, Abington, PA 19001 Phone: 215-886-2412 | |
Samuel Pierce, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2081 Parkview Ave, Abington, PA 19001 Phone: 215-680-3126 | |
Mr. Michael Brian Misoda, PT,GCS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Abington Memorial Hospital, 1200 Old York Road, Abington, PA 19001 Phone: 215-481-2921 | |
Jay Raju, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1915 Guernsey Ave, Abington, PA 19001 Phone: 215-659-8600 Fax: 215-659-4498 | |
Mrs. Kimberly Anne King, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1213 Osbourne Ave, Abington, PA 19001 Phone: 215-887-2971 |